Stockchase Opinions

David Driscoll Elan Corp. ELN-N DON'T BUY Feb 14, 2001

Prefers Glaxiskline
$55.100

Stock price when the opinion was issued

biotechnology pharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

DON'T BUY
Accounting is questionable.
DON'T BUY
Questionable accounting practices.
BUY
Pet adoption enjoyed a boom during the Covid lockdown. Shares have more than doubled since last year's bottom, including jumping 6% today after an excellent quarterly report. Plus, ELN is getting a boost from rising food prices. Today, they announced a blowout quarter with higher than expected earnings and sales and raised full-year guidance.